Stockscreener 앱 받기
2.8706
2.05%
-0.0594
전일 마감가:
$2.93
열려 있는:
$2.87
하루 거래량:
360.17K
Relative Volume:
0.37
시가총액:
$496.05M
수익:
-
순이익/손실:
$-54.70M
주가수익비율:
-8.6988
EPS:
-0.33
순현금흐름:
$-51.36M
1주 성능:
-6.51%
1개월 성능:
-11.69%
6개월 성능:
-14.58%
1년 성능:
-31.18%
1일 변동 폭
$2.79
$2.90
1주일 범위
$2.79
$3.1754
52주 변동 폭
$2.31
$5.11
사바라 Stock (SVRA) Company Profile
명칭
Savara Inc
전화
51285113796
주소
6836 BEE CAVE ROAD, AUSTIN, TX
SVRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
2.87 | 537.52M | 0 | -54.70M | -51.36M | -0.33 |
|
ONC
Beigene Ltd Adr
|
241.12 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.42 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.335 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.56 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
74.95 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
사바라 Stock (SVRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-20 | 개시 | Wells Fargo | Overweight |
| 2024-11-13 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-02-15 | 개시 | JMP Securities | Mkt Outperform |
| 2023-11-07 | 개시 | Guggenheim | Buy |
| 2023-05-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-03-31 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-03-16 | 개시 | Piper Sandler | Overweight |
| 2021-03-15 | 개시 | Oppenheimer | Outperform |
| 2019-06-13 | 재확인 | H.C. Wainwright | Buy |
| 2019-06-13 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-13 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2018-08-13 | 재개 | ROTH Capital | Neutral |
| 2018-01-03 | 개시 | Ladenburg Thalmann | Buy |
| 2017-09-27 | 재개 | ROTH Capital | Buy |
| 2017-09-22 | 개시 | Jefferies | Buy |
| 2017-09-11 | 개시 | JMP Securities | Mkt Outperform |
모두보기
사바라 주식(SVRA)의 최신 뉴스
Savara Inc. (SVRA): Analysts See 212% Upside Potential - MSN
Savara Announces Participation in Jefferies Global Healthcare Conference | SVRA Stock News - GuruFocus
Savara Announces Participation in Jefferies Global Healthcare Conference - Bluefield Daily Telegraph
Deutsche Bank AG Acquires 53,054 Shares of Savara Inc (NASDAQ:SVRA) - Defense World
Savara Reports Q1 2025 Financial Results and Advances Key Milestones - MSN
Savara Inc. Announces Equity Awards for New Employees - MSN
Savara Presented New Data From Pivotal Phase 3 IMPALA-2 Trial of - GuruFocus
Savara (SVRA) Announces Positive Phase 3 Trial Results for Molgramostim | SVRA Stock News - GuruFocus
Savara Presented New Data From Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at American Thoracic - GuruFocus
Savara Presented New Data From Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at American Thoracic Society Conference (ATS) 2025 - Yahoo Finance
Price T Rowe Associates Inc. MD Boosts Stock Position in Savara Inc (NASDAQ:SVRA) - Defense World
Savara Inc (NASDAQ:SVRA) Shares Purchased by Dimensional Fund Advisors LP - Defense World
HC Wainwright Has Positive Forecast for Savara Q2 Earnings - Defense World
Savara (SVRA) Price Target Lowered as Molbreevi Priority Review Anticipated | SVRA Stock News - GuruFocus
Savara (SVRA) Prepares for U.S. Launch Following BLA Submission - GuruFocus
Savara Reports First Quarter 2025 Financial Results and Provides a Business Update | SVRA Stock News - GuruFocus
Savara Reports First Quarter 2025 Financial Results and Provides a Business Update - Business Wire
Autoimmune Pulmonary Alveolar Proteinosis Market to Expand Significantly by 2032, States DelveInsight Report | Savara Inc. - Barchart.com
Hsbc Holdings PLC Invests $48,000 in Savara Inc (NASDAQ:SVRA) - Defense World
Savara Announces Participation in the H.C. Wainwright & Co. 3rd Annual BioConnect Investor Conference - Stock Titan
Savara Inc.'s (NASDAQ:SVRA) recent 16% pullback adds to one-year year losses, institutional owners may take drastic measures - simplywall.st
Wells Fargo & Company MN Has $182,000 Holdings in Savara Inc (NASDAQ:SVRA) - Defense World
Savara Inc (NASDAQ:SVRA) Shares Sold by MetLife Investment Management LLC - Defense World
Analysts Set Savara Inc (NASDAQ:SVRA) Target Price at $8.83 - Defense World
Barclays PLC Grows Stake in Savara Inc (NASDAQ:SVRA) - Defense World
Metric Deep Dive: Understanding Savara Inc (SVRA) Through its Ratios - DWinneX
Raymond James Financial Inc. Buys Shares of 259,798 Savara Inc (NASDAQ:SVRA) - Defense World
Savara Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
A stock that deserves closer examination: Savara Inc (SVRA) - uspostnews.com
Savara Announces Participation in the Upcoming Citizens Life Sciences Conference - Business Wire
Legal & General Group Plc Sells 12,613 Shares of Savara Inc (NASDAQ:SVRA) - Defense World
Savara, Inc. to Host Earnings Call - ACCESS Newswire
SVRASavara Inc Latest Stock News & Market Updates - Stock Titan
Savara Inc (NASDAQ:SVRA) Shares Purchased by Geode Capital Management LLC - Defense World
JMP maintains $10 target on Savara stock post-BLA submission By Investing.com - Investing.com Nigeria
Examining Savara Inc (SVRA) more closely is necessary - uspostnews.com
JMP maintains $10 target on Savara stock post-BLA submission - Investing.com
Savara: Make-It-Or-Break-It Molbreevi BLA Filing (NASDAQ:SVRA) - Seeking Alpha
JPMorgan Chase & Co. Grows Stock Position in Savara Inc (NASDAQ:SVRA) - Defense World
Savara Inc (NASDAQ:SVRA) Shares Purchased by Vanguard Group Inc. - Defense World
Corebridge Financial Inc. Sells 4,330 Shares of Savara Inc (NASDAQ:SVRA) - Defense World
KLP Kapitalforvaltning AS Purchases Shares of 13,200 Savara Inc (NASDAQ:SVRA) - Defense World
사바라 (SVRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
사바라 주식 (SVRA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lowrance David L | Chief Financial Officer |
Dec 16 '24 |
Sale |
3.33 |
25,000 |
83,278 |
381,005 |
| Pauls Matthew | CHIEF EXECUTIVE OFFICER |
Dec 16 '24 |
Sale |
3.31 |
54,702 |
180,828 |
1,536,379 |
| Hawkins Richard J | Director |
Dec 16 '24 |
Sale |
3.32 |
8,000 |
26,569 |
67,241 |
17.27%
자본화:
|
볼륨(24시간):